Skip to Content

Rhoen Klinikum AG RHK

Morningstar Rating
€11.90 −0.30 (2.46%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

RHK is trading at a 286% premium.
Price
€11.97
Fair Value
€83.61
Uncertainty
Very High
1-Star Price
€46.84
5-Star Price
€96.85
Economic Moat
Hmmcy
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if RHK is a good fit for your portfolio.

Trading Information

Previous Close Price
€12.20
Day Range
€11.9012.10
52-Week Range
€9.5014.00
Bid/Ask
€11.80 / €12.00
Market Cap
€796.57 Mil
Volume/Avg
418 / 1,905

Key Statistics

Price/Earnings (Normalized)
11.95
Price/Sales
0.53
Dividend Yield (Trailing)
1.26%
Dividend Yield (Forward)
Total Yield
1.26%

Company Profile

Rhoen Klinikum AG provides medical care focused in five key areas: cardiovascular medicine, neuromedicine, oncology, pulmonary diseases, and orthopedic and trauma surgery. The firm operates in three business areas: acute hospitals, medical care centers, and rehabilitation hospitals. The acute hospitals business contributes to the vast majority of the firm's overall revenue. The majority of patients at the firm's acute hospitals and medical care centers are treated on an outpatient basis. Rhoen Klinikum generates the entirety of its revenue in Germany, with the Bavaria and Hesse regions contributing the largest proportions of revenue.
Sector
Healthcare
Industry
Medical Care Facilities
Stock Style Box
Small Core
Total Number of Employees
18,324

Comparables

Valuation

Metric
RHK
FME
FRE
Price/Earnings (Normalized)
11.9514.866.36
Price/Book Value
0.630.760.83
Price/Sales
0.530.540.60
Price/Cash Flow
8.584.7813.83
Price/Earnings
RHK
FME
FRE

Financial Strength

Metric
RHK
FME
FRE
Quick Ratio
2.120.880.60
Current Ratio
2.291.501.35
Interest Coverage
12.823.122.85
Quick Ratio
RHK
FME
FRE

Profitability

Metric
RHK
FME
FRE
Return on Assets (Normalized)
2.45%2.84%2.43%
Return on Equity (Normalized)
3.47%7.19%7.80%
Return on Invested Capital (Normalized)
2.67%4.44%4.23%
Return on Assets
RHK
FME
FRE
See how this stock stacks up to its competitors with Morningstar Investor

Medical Care Facilities Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
HCA Healthcare Inc
HCA
PnmmrvvNbnwp$83.0 Bil
Fresenius SE & Co KGaA
FSNUF
Dyrzmnj$17.7 Bil
Fresenius SE & Co KGaA ADR
FSNUY
Tzlxwl$17.7 Bil
Tenet Healthcare Corp
THC
RkkvgfmtpHpnn$12.8 Bil
Universal Health Services Inc Class B
UHS
Jzlpn$12.0 Bil
DaVita Inc
DVA
DmzlmwjczYlypk$11.9 Bil
Bangkok Dusit Medical Services PCL Units Non-Voting Depository Receipt
BDUUF
Bwmg$11.6 Bil
Bangkok Dusit Medical Services PCL Shs Foreign Registered
BDULF
Sdmgg$11.6 Bil
Fresenius Medical Care AG ADR
FMS
QwfWjjpk$11.5 Bil
AMN Healthcare Services Inc
AMN
LqwhbdlsGhwjws$2.0 Bil

Sponsor Center